Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.

Chang SS, Grunder S, Hanukoglu A, Rösler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP.

Nat Genet. 1996 Mar;12(3):248-53.

PMID:
8589714
2.

Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.

Edelheit O, Hanukoglu I, Gizewska M, Kandemir N, Tenenbaum-Rakover Y, Yurdakök M, Zajaczek S, Hanukoglu A.

Clin Endocrinol (Oxf). 2005 May;62(5):547-53. Review.

PMID:
15853823
3.
4.

[Mineralocorticoid resistance: pseudohypoaldosteronism type 1].

Fernandes-Rosa FL, Antonini SR.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):373-81. Review. Portuguese.

5.

Mineralocorticoid resistance.

Zennaro MC, Lombès M.

Trends Endocrinol Metab. 2004 Aug;15(6):264-70. Review.

PMID:
15358279
6.

Epithelial sodium channel, salt intake, and hypertension.

Hummler E.

Curr Hypertens Rep. 2003 Feb;5(1):11-8. Review.

PMID:
12530930
7.

Liddle syndrome: genetics and mechanisms of Na+ channel defects.

Warnock DG.

Am J Med Sci. 2001 Dec;322(6):302-7. Review.

PMID:
11780687
8.

Dysfunction of epithelial sodium transport: from human to mouse.

Bonny O, Hummler E.

Kidney Int. 2000 Apr;57(4):1313-8. Review.

PMID:
10760060
9.

Clinical and molecular features of type 1 pseudohypoaldosteronism.

Riepe FG.

Horm Res. 2009;72(1):1-9. doi: 10.1159/000224334. Epub 2009 Jun 30. Review.

10.

Sodium transporters in health and disease.

Warnock DG.

Curr Opin Nephrol Hypertens. 1997 Jul;6(4):372-6. Review.

PMID:
9263687
11.

The epithelial sodium channel in hypertension.

Warnock DG.

Curr Hypertens Rep. 1999 Apr-May;1(2):158-63. Review.

PMID:
10981060
12.

Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.

Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, Caprio M, Viengchareun S, Lombès M, Zennaro MC.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):119-25. Review.

PMID:
15134810
13.

Pseudohypoaldosteronism: mutation found, problem solved?

Kuhnle U.

Mol Cell Endocrinol. 1997 Oct 20;133(2):77-80. Review.

PMID:
9406852
14.

Polymorphism in the beta subunit and Na+ transport.

Warnock DG.

J Am Soc Nephrol. 1996 Dec;7(12):2490-4. Review.

15.

The molecular basis of hypertension.

Toka HR.

Turk J Pediatr. 2002 Jul-Sep;44(3):183-93. Review.

PMID:
12405428
16.

Mechanisms of type I and type II pseudohypoaldosteronism.

Furgeson SB, Linas S.

J Am Soc Nephrol. 2010 Nov;21(11):1842-5. doi: 10.1681/ASN.2010050457. Epub 2010 Sep 9. Review.

17.

[Pseudohypoaldosteronism].

Arai K, Naruse K, Tanabe A, Naruse M, Demura H.

Nihon Rinsho. 1996 Mar;54(3):812-8. Review. Japanese.

PMID:
8904242
18.

1996 Homer Smith Award Lecture. Cum grano salis: the epithelial sodium channel and the control of blood pressure.

Rossier BC.

J Am Soc Nephrol. 1997 Jun;8(6):980-92. Review. No abstract available.

19.

Molecular biology of Na+ absorption.

Barbry P, Hofman P.

Am J Physiol. 1997 Sep;273(3 Pt 1):G571-85. Review.

PMID:
9316461
20.

[Liddle syndrome].

Tamura H, Sasaki S.

Nihon Rinsho. 1996 Mar;54(3):807-11. Review. Japanese.

PMID:
8904241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk